Start the conversation
IMS Health Holdings Inc. (NYSE: IMS) is a global IT company that provides clients operating in the healthcare industry with industry data and consulting services. IMS hit the New York Stock Exchange on April 3.
Through the IPO, IMS raised $1.3 billion by selling 65 million shares for $20 each. Initially, the company had set a price range of $18 to $21 for its shares. JPMorgan, Goldman Sachs, and Morgan Stanley were the lead underwriters on the deal.
"They have a very stable, large, profitable legacy business, and they're looking to cross-sell additional products and value-added services into their existing client base," Allianz Global Investors' Portfolio Manager John Schroer told The Journal before the IPO.
IMS stock jumped 15% in its first day of trading. Today, the stock is up 17% from its initial offer price.
But there were a few IPOs so far in 2014 that trumped PE and IMS. Check out the year's top three…